Loading patent…
AssigneeHong Kong Baptist University
InventorsHongxi XU, Hong ZHANG, Zhichao XI, Hongsheng TAN, Kaixian CHEN, Zhaoxiang BIAN, Dajian YANG, Shilin CHEN, Aiping LU, Albert Sun Chi CHAN
Estimating the term…
A novel polyisoprenylated tetracyclic xanthone, named garciesculentone B, isolated from Garcinia esculenta Y. H. Li is disclosed in the present invention. This compound is shown to have significant cytotoxicity against various cancer cells. In addition, garciesculentone B is shown to have antimigration effect on various cancer cells such as human esophageal carcinoma cell. The experimental data supports that this compound is useful for developing into an anticancer drug.
A composition for treating cancer comprising a compound with a chemical structure of
A method for treating cancer comprising administering a composition containing a compound to a subject in needs thereof, said compound having a chemical structure of
Dependencies are inferred from the claim text.